NICD levels and Notch target genes, including Hey1, Hes1, and cyclin D1 (Ccnd1), were significantly upregulated in HG-treated Met1 cancer cells (Fig. 3a, b), suggesting that HG activates Notch signaling. This evidence concerns the gene HES1 and cancer.